These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 5738544)

  • 1. [Comparative study of the fibrinolytic activity of dimethylbiguanide in prevention of thromboembolism in patients with angiocardiopathy].
    Molino N; Belluardo C
    Rass Int Clin Ter; 1968 Jun; 48(11):687-700. PubMed ID: 5738544
    [No Abstract]   [Full Text] [Related]  

  • 2. [Therapy of arteriosclerotic vasculopathies with arterial wall extract].
    Veccia F
    Clin Ter; 1967 Sep; 42(5):429-42. PubMed ID: 5617689
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical observations on the combination citrogenase-aminoxidase-tyrosine (Vasolastine)].
    de Oliveira JM
    Hospital (Rio J); 1968 Sep; 74(3):751-4. PubMed ID: 4986696
    [No Abstract]   [Full Text] [Related]  

  • 4. [Experience with polysponin therapy of atherosclerosis].
    Milimovka ME; Konovalov MN; Rybnikov NI; Dimant MI
    Vrach Delo; 1971 Jan; (1):63-5. PubMed ID: 5576585
    [No Abstract]   [Full Text] [Related]  

  • 5. [Combined intenkordin and corhormone treatment of ischemic heart disease].
    Glukhen'kiĭ TT; Kuz'ko NV
    Vrach Delo; 1974 May; 5(0):55-7. PubMed ID: 4407764
    [No Abstract]   [Full Text] [Related]  

  • 6. [The heparin tolerance test in the treatment of regional and diffuse atherosclerotic vascular diseases].
    Guglielmi G; Barlattani M
    Clin Ter; 1971 Aug; 58(3):229-42. PubMed ID: 5135002
    [No Abstract]   [Full Text] [Related]  

  • 7. [The clofibrate-dipyridamole combination in the prevention and therapy of arteriosclerotic vascular disease and its complications].
    Cucinotta D; Ferretti PG; Daccò L; Mazzera F
    G Clin Med; 1977; 58(11-12):475-86. PubMed ID: 608558
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical study of moxisylyte hydrochloride].
    Cloarec M
    Clin Ter; 1970 Dec; 55(6):503-12. PubMed ID: 4252473
    [No Abstract]   [Full Text] [Related]  

  • 9. [Electroencephalographic findings in a group of aged subjects treated with potentiated gerovital-H3].
    Aslan A; Buşilă V; Sacerdoţeanu F
    Fiziol Norm Patol; 1968; 14(3):263-70. PubMed ID: 5686658
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of atherosclerosis with cobalt-containing preparations].
    Khodzhaev AKh; Ashirmatov AE; Mirochnik LM
    Klin Med (Mosk); 1972 Jan; 50(1):77-82. PubMed ID: 5020034
    [No Abstract]   [Full Text] [Related]  

  • 11. [The use of glucuronyl-glucosamino-glycan sulfate (3GS) in the treatment of cerebral and peripheral athero-arteriosclerotic pathology].
    Ciammaichella A; Solitro A; Torcia L; Arcuri P
    Clin Ter; 1978 Mar; 84(5):509-21. PubMed ID: 648104
    [No Abstract]   [Full Text] [Related]  

  • 12. [The effects of oral administration of a sulfo-polysaccharide of low molecular weight in a group of sedentary workers with ateriosclerotic cardiovascular disease].
    Alessandri M; Fiorentini P; Garagnani C
    G Clin Med; 1967 Sep; 48(9):935-47. PubMed ID: 4180085
    [No Abstract]   [Full Text] [Related]  

  • 13. [Use of recordil-30 in arteriosclerosis of the arteries of the heart, brain and lower extremities].
    Zadionchenko VS; Savenkov PM; Martynov AI
    Kardiologiia; 1974 Apr; 14(4):108-12. PubMed ID: 4836803
    [No Abstract]   [Full Text] [Related]  

  • 14. [Glucuronyl-glucosaminoglycan sulfate in therapy of atheroarteriosclerotic syndromes in geriatrics].
    Bompani R; Violi G
    Minerva Med; 1974 Nov; 65(83):4315-29. PubMed ID: 4279362
    [No Abstract]   [Full Text] [Related]  

  • 15. [Miscleron in the treatment of patients with atherosclerosis of the coronary and cerebal vessels].
    Sivkov II; Kukes VG; Kirichenko LL; Fedosova NS; Ishmaeva KA
    Sov Med; 1971 Sep; 34(9):54-7. PubMed ID: 5121295
    [No Abstract]   [Full Text] [Related]  

  • 16. [Sulodexide treatment approach in patients with atherosclerotic vascular disease with various localizations].
    Capone-Braga M; Tellini L; Boncompagni L; Bettoni M; Burali A; Bensi A
    Clin Ter; 1987 Jan; 120(1):25-31. PubMed ID: 2973852
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical experiences on the anti-dyslipidemic effect of a new sulfomucopolysaccharide of pancreatic origin].
    Castello S
    Clin Ter; 1971 Aug; 58(4):323-34. PubMed ID: 4258171
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical research on the aged concerning the anti-sclerotic effect of a new heparinoid extract: glycuronoglucosaminoglycan sulfate (3GS)].
    Turpini R; Caliandro L; Cocchi A; Volpi F; Brusaioli G; Grignani G; Antognetti R
    Clin Ter; 1975 May; 73(3):213-36. PubMed ID: 123842
    [No Abstract]   [Full Text] [Related]  

  • 19. [Pyridinolcarbamate treatment of ischemic heart disease].
    Kuz'ko NV
    Vrach Delo; 1976 Jan; (1):27-30. PubMed ID: 1246850
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical evaluation of a fribrinolytic drug in an experimental cross-over study].
    Bizzi B; Butti A
    Minerva Med; 1969 Dec; 60(99 Suppl):5062-7. PubMed ID: 4188590
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.